{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T19:34:30Z","timestamp":1774380870706,"version":"3.50.1"},"reference-count":84,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    The sterol response element binding proteins (SREBPs), SREBP-1a\/c and SREBP-2, are sterol-regulated transcription factors that control the expression of cholesterol and fatty acid-raising genes. Elevated expression of SREBPs has been linked to increased morbidity and mortality rates associated with conditions including obesity, cancer, and cardiovascular disease. Therefore, the development of new therapeutics to inhibit SREBP activity may be beneficial for treating various diseases associated with altered lipid levels. In their inactive state, SREBPs remain sequestered in the ER membrane in a complex with SREBP cleavage activating protein (SCAP) and one of two ER-anchoring proteins, Insig-1 or Insig-2. Activation proceeds through dissociation of SREBP\/SCAP from Insigs, SCAP-assisted translocation to the Golgi, proteolytic membrane release and nuclear import. We employed a high-throughput enzyme complementation assay to identify inhibitors of SREBP-2 translocation to the nucleus, resulting in the identification of VB-84922 having an IC\n                    <jats:sub>50<\/jats:sub>\n                    value of 0.45 \u00b1 0.052\u00a0\u03bcM. VB-84922-mediated inhibition of nuclear translocation was confirmed by fluorescence microscopy with an mNeonGreen-SREBP-2 fusion protein. Crucially, VB-84922 inhibited the lovastatin-induced activity of an SREBP-responsive reporter construct and suppressed the expression of endogenous SREBP target genes. Co-transfection assays using an SREBP reporter and fluorescence microscopy were used to delineate the target of VB-84922 in the SREBP activation pathway. The drug blocked ER export of wild-type SCAP but had no effect on SREBP activity in cells expressing the nuclear form of SREBP-1a, or mutated versions of SCAP that are unable to bind Insigs and that chaperone SREBP to the Golgi constitutively. These results suggest that VB-84922 targets a step upstream of ER export in the SREBP activation cascade. VB-87496, a therapeutic lead compound, developed from VB-84922, demonstrated\n                    <jats:italic>in vivo<\/jats:italic>\n                    efficacy within a murine acute fasting-refeeding model by inhibiting full-length SREBP protein maturation and SREBP-dependent transcription. VB-87496 represents a specific SREBPs-SCAP inhibitor that has potential for further lead optimization medicinal chemistry efforts to generate a potent and selective pre-clinical candidate for treating lipid-related diseases.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2026.1732319","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T16:17:06Z","timestamp":1774369026000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["VB-84922 is a small molecule that inhibits ER-to-golgi transport of SREBPs-SCAP complexes"],"prefix":"10.3389","volume":"17","author":[{"given":"J. Jose","family":"Corbalan","sequence":"first","affiliation":[{"name":"The Institute of Metabolic Disorders, Genesis Research and Development Institute, Genesis Biotechnology Group","place":["Hamilton, NJ, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wiebke","family":"Schormann","sequence":"additional","affiliation":[{"name":"Sunnybrook Research Institute","place":["Toronto, ON, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pranavi","family":"Jagadeesan","sequence":"additional","affiliation":[{"name":"The Institute of Metabolic Disorders, Genesis Research and Development Institute, Genesis Biotechnology Group","place":["Hamilton, NJ, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Kale","sequence":"additional","affiliation":[{"name":"Sunnybrook Research Institute","place":["Toronto, ON, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Chiang","family":"Huang","sequence":"additional","affiliation":[{"name":"Venenum Biodesign Inc., Genesis Biotechnology Group","place":["Hamilton, NJ, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachael","family":"Siegel","sequence":"additional","affiliation":[{"name":"Venenum Biodesign Inc., Genesis Biotechnology Group","place":["Hamilton, NJ, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James R.","family":"Beasley","sequence":"additional","affiliation":[{"name":"Venenum Biodesign Inc., Genesis Biotechnology Group","place":["Hamilton, NJ, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyun-Peng","family":"Tung","sequence":"additional","affiliation":[{"name":"City St. George\u2019s, University of London","place":["London, United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Nohturfft","sequence":"additional","affiliation":[{"name":"City St. George\u2019s, University of London","place":["London, United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Andrews","sequence":"additional","affiliation":[{"name":"Sunnybrook Research Institute","place":["Toronto, ON, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Joseph T.","family":"Nickels","sequence":"additional","affiliation":[{"name":"The Institute of Metabolic Disorders, Genesis Research and Development Institute, Genesis Biotechnology Group","place":["Hamilton, NJ, United States"]},{"name":"Rutgers Center for Lipid Research, New Jersey Institute for Food, Nutrition, and Health, Rutgers University","place":["New Brunswick, NJ, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"52772","DOI":"10.1074\/jbc.M410302200","article-title":"Cholesterol and 25-hydroxycholesterol inhibit activation of SREBPs by different mechanisms, both involving SCAP and insigs","volume":"279","author":"Adams","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1194\/jlr.M100417-JLR200","article-title":"Transcriptional activities of nuclear SREBP-1a, -1c, and -2 to different target promoters of lipogenic and cholesterogenic genes","volume":"43","author":"Amemiya-Kudo","year":"2002","journal-title":"J. Lipid Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e596","DOI":"10.1161\/CIR.0000000000000678","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"B4","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s10557-019-06904-x","article-title":"State of the art comprehensive review of individual statins, their differences, pharmacology, and clinical implications","volume":"33","author":"Azemawah","year":"2019","journal-title":"Cardiovasc Drugs Ther."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2337\/db05-0742","article-title":"Leptin suppresses stearoyl-CoA desaturase 1 by mechanisms independent of insulin and sterol regulatory element-binding protein-1c","volume":"55","author":"Biddinger","year":"2006","journal-title":"Diabetes"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-025-01893-y","article-title":"Novel start codon variant in the 5'UTR of LDLR associated with familial hypercholesterolaemia","author":"Bird","year":"2025","journal-title":"Eur. J. Hum. Genet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0197-2456(95)00002-x","article-title":"Dose-ranging trials: guidelines for data collection and standardized descriptions","volume":"16","author":"Boissel","year":"1995","journal-title":"Control Clin. Trials"},{"key":"B8","doi-asserted-by":"publisher","first-page":"14490","DOI":"10.1016\/S0021-9258(19)85265-1","article-title":"Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. I. Identification of the protein and delineation of its target nucleotide sequence","volume":"268","author":"Briggs","year":"1993","journal-title":"J. Biol. Chem."},{"key":"B9","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/s0092-8674(00)80213-5","article-title":"The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor","volume":"89","author":"Brown","year":"1997","journal-title":"Cell"},{"key":"B10","doi-asserted-by":"publisher","first-page":"11041","DOI":"10.1073\/pnas.96.20.11041","article-title":"A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood","volume":"96","author":"Brown","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B11","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1146\/annurev-biochem-062917-011852","article-title":"Retrospective on cholesterol homeostasis: the central role of scap","volume":"87","author":"Brown","year":"2018","journal-title":"Annu. Rev. Biochem."},{"key":"B12","doi-asserted-by":"publisher","first-page":"n1537","DOI":"10.1136\/bmj.n1537","article-title":"Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses","volume":"374","author":"Cai","year":"2021","journal-title":"BMJ"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1016\/j.cmet.2022.10.007","article-title":"MGAT2 inhibitor decreases liver fibrosis and inflammation in murine NASH models and reduces body weight in human adults with obesity","volume":"34","author":"Cheng","year":"2022","journal-title":"Cell Metab."},{"key":"B14","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.tips.2005.02.007","article-title":"The efficiency of multi-target drugs: the network approach might help drug design","volume":"26","author":"Csermely","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/CRD.0000000000000498","article-title":"Antihyperlipidemic treatment options in Statin resistance and intolerance","volume":"32","author":"Danilov","year":"2024","journal-title":"Cardiol. Rev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"9278","DOI":"10.1021\/acs.jmedchem.3c00449","article-title":"Molecular glue discovery: current and future approaches","volume":"66","author":"Dewey","year":"2023","journal-title":"J. Med. Chem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"6373","DOI":"10.1021\/jm049902r","article-title":"Deriving knowledge through data mining high-throughput screening data","volume":"47","author":"Diller","year":"2004","journal-title":"J. Med. Chem."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1161\/01.ATV.0000134621.14315.43","article-title":"Statins upregulate PCSK9, the gene encoding the proprotein convertase neural apoptosis-regulated convertase-1 implicated in familial hypercholesterolemia","volume":"24","author":"Dubuc","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"12778","DOI":"10.1074\/jbc.272.19.12778","article-title":"Cleavage site for sterol-regulated protease localized to a leu-ser bond in the lumenal loop of sterol regulatory element-binding protein-2","volume":"272","author":"Duncan","year":"1997","journal-title":"J. Biol. Chem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"17801","DOI":"10.1074\/jbc.273.28.17801","article-title":"Second-site cleavage in sterol regulatory element-binding protein occurs at transmembrane junction as determined by cysteine panning","volume":"273","author":"Duncan","year":"1998","journal-title":"J. Biol. Chem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.biochi.2004.09.018","article-title":"SREBP transcription factors: master regulators of lipid homeostasis","volume":"86","author":"Eberle","year":"2004","journal-title":"Biochimie"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1172\/JCI20978","article-title":"Overexpression of Insig-1 in the livers of transgenic mice inhibits SREBP processing and reduces insulin-stimulated lipogenesis","volume":"113","author":"Engelking","year":"2004","journal-title":"J. Clin. Invest"},{"key":"B23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.chembiol.2020.10.003","article-title":"Dipyridamole inhibits lipogenic gene expression by retaining SCAP-SREBP in the endoplasmic reticulum","volume":"28","author":"Esquejo","year":"2021","journal-title":"Cell Chem. Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e0254631","DOI":"10.1371\/journal.pone.0254631","article-title":"The economic impact of hypercholesterolemia and mixed dyslipidemia: a systematic review of cost of illness studies","volume":"16","author":"Ferrara","year":"2021","journal-title":"PLoS One"},{"key":"B25","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41586-025-09297-0","article-title":"ACLY inhibition promotes tumour immunity and suppresses liver cancer","volume":"645","author":"Gautam","year":"2025","journal-title":"Nature."},{"key":"B26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1006\/abbi.2001.2615","article-title":"Mutant mammalian cells as tools to delineate the sterol regulatory element-binding protein pathway for feedback regulation of lipid synthesis","volume":"397","author":"Goldstein","year":"2002","journal-title":"Arch. Biochem. Biophys."},{"key":"B27","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/cpt.1193","article-title":"Adverse events associated with PCSK9 inhibitors: a real-world experience","volume":"105","author":"Gurgoze","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"B28","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.bbrc.2008.02.004","article-title":"Alternative splicing produces a constitutively active form of human SREBP-1","volume":"368","author":"Harada","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B29","doi-asserted-by":"publisher","first-page":"100987","DOI":"10.1016\/j.gendis.2023.04.022","article-title":"The roles and mechanisms of SREBP1 in cancer development and drug response","volume":"11","author":"He","year":"2024","journal-title":"Genes Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1172\/JCI2961","article-title":"Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2","volume":"101","author":"Horton","year":"1998","journal-title":"J. Clin. Invest"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1172\/JCI15593","article-title":"SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver","volume":"109","author":"Horton","year":"2002","journal-title":"J. Clin. Invest"},{"key":"B32","doi-asserted-by":"publisher","first-page":"10379","DOI":"10.1074\/jbc.271.17.10379","article-title":"Regulated cleavage of sterol regulatory element binding proteins requires sequences on both sides of the endoplasmic reticulum membrane","volume":"271","author":"Hua","year":"1996","journal-title":"J. Biol. Chem."},{"key":"B33","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1194\/jlr.M700443-JLR200","article-title":"Sterol-dependent regulation of proprotein convertase subtilisin\/kexin type 9 expression by sterol-regulatory element binding protein-2","volume":"49","author":"Jeong","year":"2008","journal-title":"J. Lipid Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.chembiol.2009.07.007","article-title":"A small molecule that blocks fat synthesis by inhibiting the activation of SREBP","volume":"16","author":"Kamisuki","year":"2009","journal-title":"Chem. Biol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e151895","DOI":"10.1172\/JCI151895","article-title":"Inhibiting SCAP\/SREBP exacerbates liver injury and carcinogenesis in murine nonalcoholic steatohepatitis","volume":"132","author":"Kawamura","year":"2022","journal-title":"J. Clin. Invest"},{"key":"B36","doi-asserted-by":"publisher","first-page":"s39","DOI":"10.1161\/ATVBAHA.107.160226","article-title":"Translational therapeutics of dipyridamole","volume":"28","author":"Kim","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/oby.2001.95","article-title":"Sterol regulatory element binding protein 1c (SREBP-1c) expression in human obesity","volume":"9","author":"Kolehmainen","year":"2001","journal-title":"Obes. Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1172\/JCI5341","article-title":"Blunted feedback suppression of SREBP processing by dietary cholesterol in transgenic mice expressing sterol-resistant SCAP(D443N)","volume":"102","author":"Korn","year":"1998","journal-title":"J. Clin. Invest"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jare.2022.05.013","article-title":"SCAP deficiency facilitates obesity and insulin resistance through shifting adipose tissue macrophage polarization","volume":"45","author":"Lee","year":"2023","journal-title":"J. Adv. Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"111011","DOI":"10.1016\/j.biopha.2020.111011","article-title":"SCAP knockout in SM22alpha-Cre mice induces defective angiogenesis in the placental labyrinth","volume":"133","author":"Li","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"B41","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.3390\/biomedicines11123280","article-title":"SREBP regulation of lipid metabolism in liver disease, and therapeutic strategies","volume":"11","author":"Li","year":"","journal-title":"Biomedicines"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1130747","DOI":"10.3389\/fphar.2023.1130747","article-title":"Key events in cancer: dysregulation of SREBPs","volume":"14","author":"Li","year":"","journal-title":"Front. Pharmacol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1038\/s41556-025-01766-y","article-title":"Cholesterol sensing by the SCAP-FAM134B complex regulates ER-phagy and STING innate immunity","volume":"27","author":"Li","year":"2025","journal-title":"Nat. Cell Biol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.molmet.2019.04.003","article-title":"An actionable sterol-regulated feedback loop modulates statin sensitivity in prostate cancer","volume":"25","author":"Longo","year":"2019","journal-title":"Mol. Metab."},{"key":"B45","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/s41391-022-00557-y","article-title":"Statins and prostate cancer-hype or hope? The biological perspective","volume":"25","author":"Longo","year":"2022","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.12177","article-title":"Identification of NPC1 as the target of U18666A, an inhibitor of lysosomal cholesterol export and Ebola infection","volume":"4","author":"Lu","year":"2015","journal-title":"Elife"},{"key":"B47","doi-asserted-by":"publisher","first-page":"12973","DOI":"10.3390\/ijms241612973","article-title":"Partial reversible inhibition of enzymes and its metabolic and pharmaco-toxicological implications","volume":"24","author":"Masson","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1101\/gad.891301","article-title":"SREBP cleavage-activating protein (SCAP) is required for increased lipid synthesis in liver induced by cholesterol deprivation and insulin elevation","volume":"15","author":"Matsuda","year":"2001","journal-title":"Genes Dev."},{"key":"B49","doi-asserted-by":"publisher","first-page":"e2005970","DOI":"10.1371\/journal.pbio.2005970","article-title":"CellProfiler 3.0: next-generation image processing for biology","volume":"16","author":"Mcquin","year":"2018","journal-title":"PLoS Biol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3803\/EnM.2017.32.1.6","article-title":"The SCAP\/SREBP pathway: a mediator of hepatic steatosis","volume":"32","author":"Moon","year":"2017","journal-title":"Endocrinol. Metab. Seoul."},{"key":"B51","doi-asserted-by":"publisher","first-page":"12848","DOI":"10.1073\/pnas.95.22.12848","article-title":"Sterols regulate processing of carbohydrate chains of wild-type SREBP cleavage-activating protein (SCAP), but not sterol-resistant mutants Y298C or D443N","volume":"95","author":"Nohturfft","year":"","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B52","doi-asserted-by":"publisher","first-page":"17243","DOI":"10.1074\/jbc.273.27.17243","article-title":"Topology of SREBP cleavage-activating protein, a polytopic membrane protein with a sterol-sensing domain","volume":"273","author":"Nohturfft","year":"","journal-title":"J. Biol. Chem."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e160326","DOI":"10.1172\/JCI160326","article-title":"Lipid balance must be just right to prevent development of severe liver damage","volume":"132","author":"Osborne","year":"2022","journal-title":"J. Clin. Invest"},{"key":"B54","doi-asserted-by":"publisher","first-page":"4772","DOI":"10.1158\/0008-5472.CAN-14-0130","article-title":"Immediate utility of two approved agents to target both the metabolic mevalonate pathway and its restorative feedback loop","volume":"74","author":"Pandyra","year":"2014","journal-title":"Cancer Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood-brain barrier: bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx"},{"key":"B56","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1358\/dot.2020.56.9.3168443","article-title":"Bempedoic acid: effect of ATP-citrate lyase inhibition on low-density lipoprotein cholesterol and other lipids","volume":"56","author":"Paton","year":"2020","journal-title":"Drugs Today (Barc)"},{"key":"B57","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1080\/13543776.2023.2291393","article-title":"SREBP inhibitors: an updated patent review for 2008-present","volume":"33","author":"Peng","year":"2023","journal-title":"Expert Opin. Ther. Pat."},{"key":"B58","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.molcel.2004.06.019","article-title":"Direct binding of cholesterol to the purified membrane region of SCAP: mechanism for a sterol-sensing domain","volume":"15","author":"Radhakrishnan","year":"2004","journal-title":"Mol. Cell"},{"key":"B59","doi-asserted-by":"publisher","first-page":"6511","DOI":"10.1073\/pnas.0700899104","article-title":"Sterol-regulated transport of SREBPs from endoplasmic reticulum to golgi: oxysterols block transport by binding to Insig","volume":"104","author":"Radhakrishnan","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B60","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1042\/bss0700221","article-title":"Control of lipid metabolism by regulated intramembrane proteolysis of sterol regulatory element binding proteins (SREBPs)","volume":"70","author":"Rawson","year":"2003","journal-title":"Biochem. Soc. Symp."},{"key":"B61","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/nrc.2016.89","article-title":"The multifaceted roles of fatty acid synthesis in cancer","volume":"16","author":"Rohrig","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1586\/14779072.6.10.1319","article-title":"Fenofibrate: treatment of hyperlipidemia and beyond","volume":"6","author":"Rosenson","year":"2008","journal-title":"Expert Rev. Cardiovasc Ther."},{"key":"B63","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.3909\/ricm19S1S0002","article-title":"PCSK9 inhibitors: mechanism of action, efficacy, and safety","volume":"19","author":"Roth","year":"2018","journal-title":"Rev. Cardiovasc Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/s0006-2952(01)00790-0","article-title":"Effect of atorvastatin, simvastatin, and lovastatin on the metabolism of cholesterol and triacylglycerides in HepG2 cells","volume":"62","author":"Scharnagl","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1083\/jcb.201904090","article-title":"A reference library for assigning protein subcellular localizations by image-based machine learning","volume":"219","author":"Schormann","year":"2020","journal-title":"J. Cell Biol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1172\/JCI118951","article-title":"Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a","volume":"98","author":"Shimano","year":"1996","journal-title":"J. Clin. Invest"},{"key":"B67","doi-asserted-by":"publisher","first-page":"e1001532","DOI":"10.1371\/journal.pbio.1001532","article-title":"Reduction of the cholesterol sensor SCAP in the brains of mice causes impaired synaptic transmission and altered cognitive function","volume":"11","author":"Suzuki","year":"2013","journal-title":"PLoS Biol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.cmet.2010.12.004","article-title":"Inhibition of SREBP by a small molecule, betulin, improves hyperlipidemia and insulin resistance and reduces atherosclerotic plaques","volume":"13","author":"Tang","year":"2011","journal-title":"Cell Metab."},{"key":"B69","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/S0022-2275(20)39138-0","article-title":"Quantitative analysis of hydrophobic amine inhibition of intracellular cholesterol transport","volume":"37","author":"Underwood","year":"1996","journal-title":"J. Lipid Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"21383","DOI":"10.1073\/pnas.0905633106","article-title":"SCAP is required for timely and proper myelin membrane synthesis","volume":"106","author":"Verheijen","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B71","doi-asserted-by":"publisher","first-page":"14497","DOI":"10.1016\/S0021-9258(19)85255-3","article-title":"Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. II. Purification and characterization","volume":"268","author":"Wang","year":"1993","journal-title":"J. Biol. Chem."},{"key":"B72","first-page":"437","article-title":"Therapeutic strategies targeting SREBP transcription factors: an update to 2024","volume":"4","author":"Wang","year":"2025","journal-title":"Acta Mater. Medica"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.3390\/pharmaceutics13111980","article-title":"Modulating the blood-brain barrier: a comprehensive review","volume":"13","author":"Whelan","year":"2021","journal-title":"Pharmaceutics"},{"key":"B74","doi-asserted-by":"publisher","first-page":"e2525043123","DOI":"10.1073\/pnas.2525043123","article-title":"Competition between a transmembrane helix on Scap and a membrane cholesterol regulates Scap-Insig interaction and SREBP activation","volume":"123","author":"Williams","year":"2026","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.3389\/fonc.2020.01510","article-title":"Targeting SREBP-2-Regulated mevalonate metabolism for cancer therapy","volume":"10","author":"Xue","year":"2020","journal-title":"Front. Oncol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"12753","DOI":"10.1073\/pnas.162488899","article-title":"Insig-2, a second endoplasmic reticulum protein that binds SCAP and blocks export of sterol regulatory element-binding proteins","volume":"99","author":"Yabe","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B77","doi-asserted-by":"publisher","first-page":"eabb2224","DOI":"10.1126\/science.abb2224","article-title":"A structure of human Scap bound to Insig-2 suggests how their interaction is regulated by sterols","volume":"371","author":"Yan","year":"2021","journal-title":"Science"},{"key":"B78","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/s0092-8674(02)00872-3","article-title":"Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER","volume":"110","author":"Yang","year":"2002","journal-title":"Cell"},{"key":"B79","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3791\/920","article-title":"Studying membrane biogenesis with a luciferase-based reporter gene assay","volume":"19","author":"Zhang","year":"2008","journal-title":"J. Vis. Exp"},{"key":"B80","doi-asserted-by":"publisher","first-page":"e70372","DOI":"10.1002\/fsn3.70372","article-title":"Effects of Omega-3 fatty acids intake on lipid metabolism and plaque volume in patients with coronary heart disease: a systematic review and dose-response meta-analysis of randomized clinical trials","volume":"13","author":"Zhang","year":"2025","journal-title":"Food Sci. Nutr."},{"key":"B81","doi-asserted-by":"publisher","first-page":"952371","DOI":"10.3389\/fonc.2022.952371","article-title":"Targeting SREBP-1-Mediated lipogenesis as potential strategies for cancer","volume":"12","author":"Zhao","year":"2022","journal-title":"Front. Oncol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1080\/15548627.2020.1757955","article-title":"Discovery of a potent SCAP degrader that ameliorates HFD-induced obesity, hyperlipidemia and insulin resistance via an autophagy-independent lysosomal pathway","volume":"17","author":"Zheng","year":"2021","journal-title":"Autophagy"},{"key":"B83","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cct.2017.08.005","article-title":"Dose-ranging design and analysis methods to identify the minimum effective dose (MED)","volume":"63","author":"Zhou","year":"2017","journal-title":"Contemp. Clin. Trials"},{"key":"B84","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/CRD.0000000000000406","article-title":"Cholesterol paradigm and beyond in atherosclerotic cardiovascular disease: cholesterol, sterol regulatory element-binding protein, inflammation, and vascular cell mobilization in Vasculopathy","volume":"30","author":"Zhou","year":"2022","journal-title":"Cardiol. Rev."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1732319\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T16:17:09Z","timestamp":1774369029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1732319\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":84,"alternative-id":["10.3389\/fphar.2026.1732319"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1732319","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"article-number":"1732319"}}